Pulnovo Medical announced that it closed a Series C funding round worth proceeds of nearly $100 million. Qiming Venture Partners and existing shareholder Lilly Asia Ventures co-led the financing. Existing investors OrbiMed and Gaorong Capital participated on a super pro-rata basis as well. Shanghai-based Pulnovo said the $100 million represents made the round oversubscribed by […]
Pulnovo Medical
Pulnovo enrolls first patients in artery denervation trial
Pulnovo Medical announced today that it enrolled the first two patients in a clinical study evaluating its pulmonary artery denervation (PADN) treatment. The company’s PADN treatment utilizes a multi-pole pulmonary artery radiofrequency (RF) ablation catheter and RF ablation generator. It aims to treat pulmonary hypertension associated with left heart disease. Pulnovo’s enrollments took place at […]
